[go: up one dir, main page]

WO2004090779A3 - Krankheitsverlaufkontrolle - Google Patents

Krankheitsverlaufkontrolle Download PDF

Info

Publication number
WO2004090779A3
WO2004090779A3 PCT/EP2004/003613 EP2004003613W WO2004090779A3 WO 2004090779 A3 WO2004090779 A3 WO 2004090779A3 EP 2004003613 W EP2004003613 W EP 2004003613W WO 2004090779 A3 WO2004090779 A3 WO 2004090779A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosing
relates
control
disease progression
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/003613
Other languages
English (en)
French (fr)
Other versions
WO2004090779A2 (de
Inventor
Wolfang Petrich
Gerhard Werner
Heinz-Michael Hein
Hans-Juergen Kuhr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Priority to CA002521921A priority Critical patent/CA2521921A1/en
Priority to EP04725920A priority patent/EP1611537A2/de
Priority to JP2006505006A priority patent/JP2006522970A/ja
Priority to US10/552,248 priority patent/US7369952B2/en
Publication of WO2004090779A2 publication Critical patent/WO2004090779A2/de
Publication of WO2004090779A3 publication Critical patent/WO2004090779A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

Die Erfindung bezieht sich auf das Gebiet von Analysemethoden, die zur Diagnose von Krankheiten an menschlichen und tierischen Proben geeignet sind. Die Erfindung offenbart ein Auswerteverfahren, durch das es möglicht wird, einzelne Krankheitsstadien zu diagnostizieren, so dass der Verlauf einer Krankheit abgebildet werden kann. Hierdurch können eine Früherkennung von Krankheiten sowie Therapiekontrollen etc. geleistet werden. Das erfindungsgemässe Verfahren macht sich multivariable Auswerteverfahren zunutzen, die im Stand der Technik zur Klassifizierung von Proben bekannt sind. Anders als im Stand der Technik erfolgt jedoch erfindungsgemäss keine Zuordnung einer Probe zu einer Klasse, sondern eine Einordnung in einen Datensatz, der sich aus der Interpolation zwischen verschiedenen Klassen ergibt.
PCT/EP2004/003613 2003-04-08 2004-04-06 Krankheitsverlaufkontrolle Ceased WO2004090779A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002521921A CA2521921A1 (en) 2003-04-08 2004-04-06 Control for a disease progression
EP04725920A EP1611537A2 (de) 2003-04-08 2004-04-06 Krankheitsverlaufkontrolle
JP2006505006A JP2006522970A (ja) 2003-04-08 2004-04-06 疾患の進行のための制御
US10/552,248 US7369952B2 (en) 2003-04-08 2004-04-06 Quantification of disease progression by means of interpolation between parameters based on electromagnetic spectra

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10315877.4 2003-04-08
DE10315877A DE10315877B4 (de) 2003-04-08 2003-04-08 Krankheitsverlaufkontrolle

Publications (2)

Publication Number Publication Date
WO2004090779A2 WO2004090779A2 (de) 2004-10-21
WO2004090779A3 true WO2004090779A3 (de) 2005-08-11

Family

ID=33154103

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/003613 Ceased WO2004090779A2 (de) 2003-04-08 2004-04-06 Krankheitsverlaufkontrolle

Country Status (6)

Country Link
US (1) US7369952B2 (de)
EP (1) EP1611537A2 (de)
JP (1) JP2006522970A (de)
CA (1) CA2521921A1 (de)
DE (1) DE10315877B4 (de)
WO (1) WO2004090779A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007116295A2 (en) * 2006-04-07 2007-10-18 Kantonsspital Bruderholz Individual assessment and classification of complex diseases by a data-based clinical disease profile
GB0706398D0 (en) * 2007-04-02 2007-05-09 Univ Hospital Of North Staford Improvements in and relating to copd determination
US20090056994A1 (en) * 2007-08-31 2009-03-05 Kuhr Werner G Methods of Treating a Surface to Promote Metal Plating and Devices Formed
WO2009029871A1 (en) 2007-08-31 2009-03-05 Zettacore, Inc. Methods of treating a surface to promote binding of molecule(s) of interest, coatings and devices formed therefrom
WO2009086441A2 (en) * 2007-12-27 2009-07-09 Zettacore, Inc. Self-contained charge storage molecules for use in molecular capacitors
US8586798B2 (en) * 2008-07-14 2013-11-19 Esionic Es, Inc. Heat transfer medium, phosphonium ionic liquids, and methods of making
US8907133B2 (en) 2008-07-14 2014-12-09 Esionic Es, Inc. Electrolyte compositions and electrochemical double layer capacitors formed there from
US8927775B2 (en) 2008-07-14 2015-01-06 Esionic Es, Inc. Phosphonium ionic liquids, salts, compositions, methods of making and devices formed there from
DE102008039199A1 (de) * 2008-08-22 2010-02-25 Biosigna Gmbh Medical Diagnostics Verfahren und computerimplementiertes System zur Klassifizierung von Datensätzen
EP2344890B1 (de) * 2008-10-20 2021-08-11 Liposcience, Inc. Lipoprotein-insulinresistenzinidizes und zugehörige verfahren
KR101958606B1 (ko) 2010-07-06 2019-03-14 아토테크 도이칠란드 게엠베하 인쇄회로기판의 제조 방법
KR101774906B1 (ko) 2010-07-06 2017-09-05 나믹스 코포레이션 인쇄회로기판에서 사용하기 위한 유기 기판에의 접착을 향상시키는 구리 표면의 처리 방법
DE102011084636B4 (de) * 2011-10-17 2022-12-22 Endress+Hauser Conducta Gmbh+Co. Kg Verfahren zur Erkennung und/oder Bewertung geräte- und/oder prozessbedingter Störungen eines Messsignals
CN109920024B (zh) * 2019-01-29 2023-02-03 深圳市科曼医疗设备有限公司 一种心电向量环的绘制方法和装置
US12011057B2 (en) * 2020-01-13 2024-06-18 Msa Technology, Llc Safety helmet

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0644412A2 (de) * 1993-09-17 1995-03-22 Roche Diagnostics GmbH Verfahren zur Analyse klinisch relevanter Flüssigkeiten und Suspensionen
WO2000065366A1 (en) * 1999-04-22 2000-11-02 Lipomed, Inc. Nmr-method for determining the risk of developing type 2 diabetes
WO2001092859A1 (en) * 2000-06-02 2001-12-06 Medicometrics Aps Method and system for classifying a biological sample
WO2002023971A2 (en) * 2000-09-18 2002-03-28 Instrumentation Metrics, Inc. A multi-tier method of classifying sample spectra for non-invasive blood analyte prediction
WO2002041234A2 (en) * 2000-11-06 2002-05-23 Illumigen Biosciences, Inc. System and method for selectively classifying a population
WO2002086478A2 (en) * 2001-04-23 2002-10-31 Metabometrix Limited Methods for analysis of spectral data and their applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290705A (en) 1992-01-13 1994-03-01 R. E. Davis Chemical Corporation Speciman support for optical analysis
US5435309A (en) * 1993-08-10 1995-07-25 Thomas; Edward V. Systematic wavelength selection for improved multivariate spectral analysis
DE4331596A1 (de) * 1993-09-17 1995-03-23 Boehringer Mannheim Gmbh Verfahren zur quantitativen Analyse von Probenflüssigkeiten
US6031232A (en) * 1995-11-13 2000-02-29 Bio-Rad Laboratories, Inc. Method for the detection of malignant and premalignant stages of cervical cancer
US6214550B1 (en) * 1997-06-27 2001-04-10 Pacific Northwest Research Institute Methods of differentiating metastatic and non-metastatic tumors
ATE360809T1 (de) * 2001-01-22 2007-05-15 Andreas Wolf Schnelltest für biologische substanzen mittels ftir
DE10109901B4 (de) * 2001-02-22 2004-02-05 Bundesrepublik Deutschland vertreten durch den Bundesminister für Gesundheit, dieses vertreten durch das Robert-Koch-Institut, vertreten durch seinen Leiter Verfahren zum Nachweis von TSE-induzierten Veränderungen in menschlichen und tierischen Körperflüssigkeiten
EP1329716A1 (de) 2002-01-16 2003-07-23 Roche Diagnostics GmbH Verfahren zum Austesten biologischer Proben auf Vorliegen von Stoffwechselsyndrom

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0644412A2 (de) * 1993-09-17 1995-03-22 Roche Diagnostics GmbH Verfahren zur Analyse klinisch relevanter Flüssigkeiten und Suspensionen
WO2000065366A1 (en) * 1999-04-22 2000-11-02 Lipomed, Inc. Nmr-method for determining the risk of developing type 2 diabetes
US6518069B1 (en) * 1999-04-22 2003-02-11 Liposcience, Inc. Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders
WO2001092859A1 (en) * 2000-06-02 2001-12-06 Medicometrics Aps Method and system for classifying a biological sample
WO2002023971A2 (en) * 2000-09-18 2002-03-28 Instrumentation Metrics, Inc. A multi-tier method of classifying sample spectra for non-invasive blood analyte prediction
WO2002041234A2 (en) * 2000-11-06 2002-05-23 Illumigen Biosciences, Inc. System and method for selectively classifying a population
WO2002086478A2 (en) * 2001-04-23 2002-10-31 Metabometrix Limited Methods for analysis of spectral data and their applications

Also Published As

Publication number Publication date
DE10315877A1 (de) 2004-11-11
EP1611537A2 (de) 2006-01-04
WO2004090779A2 (de) 2004-10-21
CA2521921A1 (en) 2004-10-21
US20060195296A1 (en) 2006-08-31
JP2006522970A (ja) 2006-10-05
DE10315877B4 (de) 2005-11-17
US7369952B2 (en) 2008-05-06

Similar Documents

Publication Publication Date Title
WO2004090779A3 (de) Krankheitsverlaufkontrolle
WO2005023086A3 (en) Systems, methods, and computer program products for analysis of vessel attributes for diagnosis, disease staging, and surgical planning
AU2003269772A1 (en) Method and arrangement for interpreting a subjects head and eye activity
EP2293209A3 (de) Verfahren und Gerät zum Nachweis und zur Vorhersage biologischer Anomalien und Hirnschädigungen
WO2004090550A3 (en) A method for detection of colorectal cancer in human samples
EP1480251A3 (de) Analyse komplexer Mischungen von biologischen und anderen Flüssigkeiten zur Erfassung ihrer Biologischen Eigenschaften.
WO2006060799A3 (en) Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis
MXPA03011650A (es) Metodos y aparatos para personalizar alimento para mascotas.
WO2005115014A3 (en) Method, system, and program product for measuring audio video synchronization
EP1418523A3 (de) Diagnoseunterstützungssystem für Diabetes
WO2005108989A3 (en) Assay for antibodies
EP1922325A4 (de) Methoden für die diagnose von demenz und anderen neurologischen erkrankungen
WO2004052175A3 (en) Methods for rapid identification of pathogens in humans and animals
AU2003251022A1 (en) Method for monitoring accumulated body fatigue for determining recovery during exercise or activity
WO2004111611A3 (en) Multielectrode array and system for recording and analyzing data or for stimulating tissue
WO1997012992A3 (en) Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore
EP1244047A3 (de) Verfahren zum Bereitstellen von klinisch-diagnostischen Diensten
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
WO2004059282A3 (en) Method and means for early detection of pregnancy in animals by combination testing
EP1617214A4 (de) Verfahren zur erzeugung eines krankheitsprognosemodells, verfahren zur vorhersage einer krankheitsprognose unter verwendung des modells, vorrichtung zur vorhersage einer krankheitsprognose unter verwendung des modells, deren programm und aufzeichnungsmedium
WO2005103300A3 (en) Pattern recognition method for diagnosis of systemic autoimmune diseases
WO2006107962A8 (en) Methods and products for evaluating an immune response to a therapeutic protein
WO2005033334A3 (de) Verfahren zur bestimmung einer wirkstoffdosierung
WO2001071636A3 (en) Personalized health profiling system and method
EP1517140A3 (de) Verfahren und vorrichtung zur untrersuchung von biologischen proben

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004725920

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006195296

Country of ref document: US

Ref document number: 2006505006

Country of ref document: JP

Ref document number: 10552248

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2521921

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2004725920

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10552248

Country of ref document: US